00:37:05 EDT Tue 19 Mar 2024
Enter Symbol
or Name
USA
CA



Isodiol International Inc
Symbol ISOL
Shares Issued 300,779,584
Close 2018-04-24 C$ 0.85
Market Cap C$ 255,662,646
Recent Sedar Documents

Isodiol, Level to begin selling CBD products in summer

2018-04-24 07:51 ET - News Release

Mr. Marcos Agramont reports

ISODIOL INTERNATIONAL INC. ANNOUNCES THE LAUNCH OF 3 NEW CANNABIDIOL (CBD) PRODUCT CATEGORIES WITH LEVEL BRANDS INC.

Isodiol International Inc. and Level Brands Inc. have launched their newest jointly developed cannabidiol (CBD) products. The products are CBD pain-relieving cream, marketed under LEVB subsidiary Ireland Men One (I'M1); CBD oral sprays marketed under BeTru | kathy ireland health and wellness; and CBD edibles, marketed under Chef Andre Carthen Edibles. The new products will be available in early summer 2018 at in-store and on-line retailers nationwide. According to The Hemp Business Journal (as reported by Forbes), the CBD market will grow to $2.1-billion by 2020.

In January, 2018, Level Brands and Isodiol signed a licence agreement to work together to develop consumer products for kathy ireland health and wellness, a licensor to Level Brands; products under the Chef Andre Carthen and Nicholas Walker brands, also licensors to Level Brands; as well as products for Level Brands subsidiary I'M1, the company's lifestyle brand for millennial men.

"Our collaboration with Level Brands is taking a big step forward today," said Marcos Agramont, chief executive officer of Isodiol. "When we established this partnership, we envisioned bringing a variety of consistent, highly bioactive CBD products to the market and today is just the early stages of this process. Through Kathy's large network and consumer base, not only are we able to target a variety of new mainstream channels, but we are also able to further achieve our goal of helping people around the globe understand how CBD is beneficial for the human body."

"When we announced the extension of our licence agreement with Isodiol this past January, we said that our vision is that Isodiol will become the leading CBD company in the world," says Kathy Ireland, Level Brands' chairman emeritus and chief brand strategist. "The products we're launching take us in that direction in a powerful way. We continue to believe, based on our exhaustive research and decades of brand building, that the CBD industry will see enormous growth over the next decade on a global scale. Hemp has many natural and important uses that are beneficial in countless ways. It is important for people to remember that hemp, without THC, is similar to a grape without fermentation. It has no undesired psychological side effects. The Level Brands and Isodiol collaboration is bringing, and will continue to bring to market, the best quality hemp-derived CBD products, without any psychotropic elements."

About Isodiol International Inc.

Isodiol International is the market leader in pharmaceutical-grade phytochemical compounds and the industry leader in the manufacturing and development of CBD consumer products.

Isodiol is the pioneer of many firsts for the cannabis industry including commercialization of 99-per-cent-plus-pure, bioactive pharmaceutical-grade cannabinoids, microencapsulations and nanotechnology for the highest quality consumable and topical skin care products.

Isodiol's growth strategy includes the development of over-the-counter and pharmaceutical drugs, expanding its phytoceutical portfolio, and will aggressively continue international expansion into Latin America, Asia and Europe.

We seek Safe Harbor.

© 2024 Canjex Publishing Ltd. All rights reserved.